Scherbakov Nadja, Haeusler Karl Georg, Doehner Wolfram
Center for Stroke Research Berlin (CSB), Charite Universitätsmedizin Berlin, Berlin, Germany.
German Center for Cardiovascular Diseases (DZHK), Berlin, Germany.
ESC Heart Fail. 2015 Mar;2(1):1-4. doi: 10.1002/ehf2.12026. Epub 2015 Mar 30.
Heart failure (HF) is pandemic in the modern society. Comorbidities of HF come increasingly to the fore in today's patient presentation and demand multidisciplinary treatment concepts. Ischemic stroke is a major comorbidity in HF patients and frequently contributes to the adverse outcome and functional dependency. Patients with HF are two-fold to three-fold more likely to suffer an ischemic stroke, have more than two times higher mortality and show worse functional outcome after stroke compared with non-HF subjects. The risk of recurrent stroke is about two-fold elevated in patients with HF. The risk of stroke increased with time duration of HF from 18 per 100 cases in the first year of HF to 47 per 1000 patients within the next 4-5 years. Moreover, so called 'silent' strokes (clinically asymptomatic brain lesions) are two to four times more likely in HF patients. In turn, 10-24% of stroke patients have HF. Specific characteristics of the interaction between ischemic stroke and HF have been uncovered in recent years. However, gaps in present knowledge need to be addressed in future studies. What are the detailed pathophysiologic links beyond atrial fibrillation, stroke patterns, and time courses in the interaction? What implication has HF with preserved versus reduced ejection fraction? Does treatment of HF prevents ischemic stroke or reduces stroke-related sequelae? This editorial provides a condensed overview on current insights and presents facts and numbers on the interaction between heart failure and ischemic stroke.
心力衰竭(HF)在现代社会中广泛存在。在当今的患者表现中,HF的合并症日益凸显,需要多学科治疗理念。缺血性卒中是HF患者的主要合并症,经常导致不良后果和功能依赖。与非HF患者相比,HF患者发生缺血性卒中的可能性高出两到三倍,死亡率高出两倍多,且卒中后功能结局更差。HF患者复发性卒中的风险大约高出一倍。卒中风险随着HF病程的延长而增加,从HF第一年的每100例18例增加到接下来4 - 5年内每1000例患者中的47例。此外,所谓的“无症状”卒中(临床无症状脑损伤)在HF患者中的发生可能性是正常人的两到四倍。反过来,10 - 24%的卒中患者患有HF。近年来已经发现了缺血性卒中和HF之间相互作用的一些特定特征。然而,现有知识的空白需要在未来的研究中加以解决。除房颤、卒中模式和相互作用的时间进程之外,详细的病理生理联系是什么?射血分数保留型与射血分数降低型HF有何影响?HF的治疗能否预防缺血性卒中或减少卒中相关后遗症?这篇社论简要概述了当前的见解,并呈现了关于心力衰竭和缺血性卒中之间相互作用的事实和数据。